marketwatch
This is why Merck is buying a flu biotech for $9.2 billion and Wall Street is happy
MarketWatch • 3 MONTHS AGO
Applied Materials’ guidance didn’t impress. Here’s why some analysts are still upbeat.
MarketWatch • 3 MONTHS AGO
If you thought getting approved for Medicaid was hard, wait until you try to use it for this
MarketWatch • 3 MONTHS AGO
This billionaire CEO says stablecoins will matter to you — even if you don’t own crypto
MarketWatch • 3 MONTHS AGO
Only one analyst has a sell rating on Nvidia — and he says ‘it feels fantastic’
MarketWatch • 3 MONTHS AGO
‘Santa Flaws Rally’ has legs so don’t sell stocks yet, advises Bank of America strategist
MarketWatch • 3 MONTHS AGO
Here are November’s worst-performing S&P 500 stocks so far — including some surprises
MarketWatch • 3 MONTHS AGO